Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co LtdfiledCriticalGrelan Pharmaceutical Co Ltd
Priority to JP5852776ApriorityCriticalpatent/JPS52142080A/en
Publication of JPS52142080ApublicationCriticalpatent/JPS52142080A/en
PURPOSE: The title compounds, useful as anticarcinogens, especially for carcer of the gastro-intestinal tract, breast, etc., from 5-fluorouracil alkali metal salts, etc.
COPYRIGHT: (C)1977,JPO&Japio
JP5852776A1976-05-221976-05-22Preparation of n1-(2'-tetrahydrofuranyl)-5-fluorouracil
PendingJPS52142080A
(en)